Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Euronext Paris  >  PCAS    PCA   FR0000053514

PCAS (PCA)

Delayed Quote. Delayed  - 02/08 05:58:14 am
7.47 EUR   -3.74%
02/02 PCAS : 2015 sales - strong growth
2015 PCAS : Sales as of 30 september 2015, +4.8 % growth
2015 PCAS : ADEME acquires a stake in ENERSENS
SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 
Latest news on PCAS
02/02 PCAS : 2015 sales - strong growth
2015 PCAS : Sales as of 30 september 2015, +4.8 % growth
2015 PCAS : ADEME acquires a stake in ENERSENS
2015 PCAS : Ademe acquires a stake in enersens as part of the 'investments for the fu..
2015 PCAS : ex-dividend day for interim dividend
2015 PCAS : 2015 HYR - Very good operational performance Pharma focus yields strong g..
2015 PCAS : Sustained growth in net sales for the first half of 2015
2015 PCAS : Participation de PCAS au Forum d’affaires France-Chine à Paris le 1..
2015 PCAS : takes part in the China-France Business Forum held in Paris on July 1st, ..
2015 PCAS : reinforces its management team and hires several new staff members within..
2015 PCAS : reinforces its management team and hires several new staff members within..
2015 PCAS : Strengthens its foothold in pharmaceuticals in north america
2015 PCAS : 2015 - 2016 financial calendar
2015 PCAS : Obtains the "innovative business" label awarded by bpifrance
2015 PCAS : ex-dividend day for annual dividend
2015 PCAS : Sales as of march 31, 2015
2015 PCAS : Confirmation of PEA-PME plan eligibility for 2015/2016
2015 PCAS : MOONLINER® by ENERSENS: ultra-insulating natural-based wall cladding
2015 PCAS : 2014 Results - Strong Financials and growth prospects lead to return to d..
2015 PCAS : Expansia has been nominated by UCB Pharma "Vendor of the year 2014"
2014 PCAS : ENERSENS Homeskin project
2014 PCAS : leads the European Union Horizon 2020 Homeskin
2014 PCAS : includes a new Scientific Board in its governance
2014 PCAS : Protéus : At the heart of the Vadébio project
2014 PCAS : joins the new EnterNext© PEA-PME 150 index
2014 PCAS : through its subsidiary Proteus, is contributing to the conversion of wood..
2014 PCAS : joins the new EnterNext© PEA-PME 150 index
2014 PCAS : Quarterly Financial Information as of 30 September 2014
2014 PCAS : and its subsidiary Protéus at the heart of the Green Epoxy project
2014 PCAS : Successful closing of a EuroPP and a syndicated loan for a total of €45m
2014 PCAS : 2014 half-year results
2014 PCAS : 2014 first-half sales
2014 PCAS : PCAS: QUARTERLY FINANCIAL INFORMATION As of March 31, 2014
2014 PCAS : Glycopyrrolate
2014 PCAS : CHBD in China & CPHI in Japan
2014 PCAS : CHBD in China & CPHI in Japan
2014 PCAS : Gycopyrrolate
2014 PCAS : PEA-PME plan eligibility
2014 PCAS : Collaboration with Actavis for a new drug substance in late clinical phas..
2014 PCAS : Resignation and appointment of directors
2014 PCAS : Resignation and appointment of directors
2014 PCAS : 2013 results
2014 PCAS : 2013 Net Sales
2014 PCAS : Contract entered into by PCAS-Protéus and Michelin
2014 PCAS : Promising contract entered into by Protéus and Michelin for developing in..
2013 PCAS : Quarterly Financial Information As of September 30, 2013
2013 PCAS : 2013 first-half results
2013 PCAS : 2013 First-Half Sales
2013 PCAS : - dynaction merger
2013 PCAS : ENERSENS, a subsidiary dedicated to superinsulating materials, finances i..
2013 PCAS : quarterly financial information as of March 31, 2013
2013 PCAS : proposed merger between PCAS and Dynaction
2013 PCAS : sale of SBS
2013 PCAS : Strong earnings growth in 2012, Sale of SBS
2013 PCAS : 2012 net sales
2012 PCAS : Quarterly financial information at september 30th, 2012
2012 PCAS : Business buoyant over the first half of 2012 - Strong growth in results
2012 PCAS : 2012 First-half sales
2012 PCAS : expands US office
2012 PCAS : Quarterly Financial Information as of March 31st 2012
2012 PCAS : 2011 results
2012 PCAS : 2011 sales
2012 PCAS : Clinigen and PCAS sign long-term supply agreement
2012 PCAS : and Clinigen sign long-term supply agreement for the production of Foscav..
2012 PCAS : La production du principe actif : un levier stratégique pour optimiser le..
2011 PCAS : Extension of the manufacturing between VLG Chem and Sanofi
2011 PCAS : Extension of the manufacturing contract between VLG Chem and Sanofi until..
2011 PCAS : New U.S. Patent for Directed Evolution technology Granted to Proteus
2011 PCAS : quarterly financial reporting Sep 30, 2011
2011 PCAS : 2011 half-year results
2011 PCAS : Results of the bondholders vote on the resolutions presented at the Gener..
2011 PCAS : 2011 first-half sales
2011 PCAS : debt restructured
2011 PCAS : 1st quarter 2011 financial reporting
2011 PCAS : Governance: pcas strengthens itself
1  2Next
Advertisement
News chart
Full-screen chart
Income Statement Evolution
More Financials